Tomorrow’s access & affordability solutions today

In this webinar, field reimbursement leaders from across the industry's most complex access environments share what it takes to evolve a program from reactive support to a strategic access asset.

Access our case study to see how one pharmaceutical brand responded to declining access as competition increased and prior authorization pressure intensified.

The disruptions that can occur between Rx capture and the patient going home with your brand fall into three categories. CoverMyMeds helps your pharmaceutical brand solve all three.

Patient abandonment risk remains even after approval when cost is a factor. CoverMyMeds layered copay solutions ensure approved claims become patient starts.

When a claim is rejected at the pharmacy with low chance of PA approval, CoverMyMeds can fill the gap by converting to paid in real time, preventing abandonment.

CoverMyMeds offers layers of comprehensive PA support for Biopharma brands, automating processes with intelligent form support and reducing provider burdens.

This is a reprint of 'The Future of Integrated Care: Redefining Specialty Medication Access and Affordability' originally published on beckershospitalreview.com on April 1, 2026.

Copay programs need to be highly scalable and flawlessly compliant in an increasingly complex healthcare space. Find out how CoverMyMeds can help.

Access and affordability challenges and their solutions are different for drug brands depending on their lifecycle stage. CoverMyMeds presented a webinar with Fierce Pharma discussing their findings, summarized here.

At HLTH USA 2025, Kevin Kettler, President of CoverMyMeds, joined fellow healthcare leaders on the panel session, “Patients Know First,” to explore how the industry can better align with the evolving expectations to ensure patients remain at the center of all decisions.